Which type of lung cancer is characterized by multicentricity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Multicentricity in Lung Cancer

Multicentricity is characteristic of bronchoalveolar carcinoma (option c), now reclassified as a subtype of lung adenocarcinoma with lepidic growth pattern.

Understanding Multicentricity in Lung Cancer

Multicentricity refers to the presence of multiple tumor foci arising simultaneously in different locations within the lungs. This characteristic is strongly associated with what was formerly known as bronchioloalveolar carcinoma (BAC), which has been reclassified in current terminology.

Historical Context and Current Classification

The term bronchioloalveolar carcinoma (BAC) has been abandoned in newer classification systems due to inconsistent usage 1. However, the entity it described still exists and is now recognized under different terminology:

  • What was formerly known as BAC is now classified as:
    • Adenocarcinoma in situ (AIS)
    • Minimally invasive adenocarcinoma (MIA)
    • Lepidic predominant adenocarcinoma (LPA) 1

Distinctive Features of Multifocal Lung Adenocarcinoma

Multifocal lung adenocarcinomas (formerly BAC) present with several distinctive characteristics:

  • Multiple ground-glass opacities (GGOs) or part-solid nodules on CT imaging 1
  • May develop solid components over time
  • Can present as few or numerous lesions
  • May show an infiltrative pattern confined to a segment/lobe or diffusely in the lung parenchyma (pneumonic type) 1
  • Decreased propensity for nodal or systemic spread compared to other lung cancers 1
  • Increased propensity to develop additional pulmonary foci 1

Epidemiology and Risk Factors

These multifocal adenocarcinomas have distinctive epidemiological features:

  • More common in women
  • Higher prevalence in non-smokers compared to other lung cancer types 1
  • Patients with multifocal adenocarcinoma have a higher chance of developing subsequent lesions 1

Staging and Classification

The American College of Chest Physicians (ACCP) panel recommends:

  • Using the T(m) designation for patients with multifocal lung cancer
  • Classifying by the highest T stage of one focus with the number of tumors in parentheses
    • Example: Four GGO lesions all measuring <2 cm would be classified as T1a(4) 1
  • The N and M designations apply to all multiple tumor foci collectively 1

Differentiating from Other Lung Cancer Types

Multicentricity is not a typical feature of the other options listed:

  • Squamous cell carcinoma typically presents as a central, endobronchial mass
  • Small cell lung cancer usually presents as a central mass with early metastasis
  • Bronchial adenocarcinoma (conventional type) typically presents as a solitary peripheral nodule
  • Bronchial carcinoid tumors are usually solitary, well-defined nodules 1

Clinical Implications

The multifocal nature of these adenocarcinomas has important clinical implications:

  • Better prognosis compared to other lung cancers with less lymph node involvement and systemic spread 1
  • Patients with solitary, small, peripheral lesions meeting strict BAC criteria have been reported to have 100% 5-year survival rates 2
  • Different therapeutic approach may be needed compared to other lung cancers
  • May be more responsive to EGFR-targeted therapies 3

Pathophysiology of Multicentricity

Research suggests that multicentricity in these adenocarcinomas may be due to:

  • Multiclonal origin (multiple primary tumors arising independently) rather than intrapulmonary spread 4
  • This explains why these tumors can present in multiple lobes simultaneously without following typical metastatic patterns

This multiclonal origin distinguishes these tumors from other lung cancers and explains their unique clinical behavior and better prognosis despite multifocal presentation.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2006

Research

Bronchioloalveolar carcinoma: a review of current concepts and evolving issues.

Archives of pathology & laboratory medicine, 2007

Research

The multifocality of bronchioloalveolar lung carcinoma: evidence and implications of a multiclonal origin.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.